Table of Contents

ABSTRACT

Fibrinolytics is a form of reperfusion therapy used to treat patients with acute myocardial infarction. Streptokinase therapy continues to benefit the elderly despite their significant risk of bleeding. We present an octogenarian patient suffering from ST-elevation myocardial infarction in a rural location. Patients received streptokinase therapy while experiencing symptomatic bradycardia. He experienced a non-hemorrhagic stroke four days after receiving streptokinase therapy and was given dual antiplatelets with changes based on clinical parameters. On day 12, the patient’s chest pain and stroke symptoms improved clinically. Fibrinolytic treatment is essential in acute myocardial infarction, particularly in rural areas. Fibrinolytic treatment in octogenarians can help reduce morbidity and death by monitoring for fibrinolytic consequences.

Keywords: octogenarians, STEMI, fibrinolytics, non-hemorrhagic stroke, case report